Envudeucitinib
N-[4-[2-methoxy-3-[1-(trideuteriomethyl)-1,2,4-triazol-3-yl]anilino]-5-(3,3,3-trideuteriopropanoyl)-2-pyridinyl]cyclopropanecarboxamide
Molecular Identity
Envudeucitinib
N-[4-[2-methoxy-3-[1-(trideuteriomethyl)-1,2,4-triazol-3-yl]anilino]-5-(3,3,3-trideuteriopropanoyl)-2-pyridinyl]cyclopropanecarboxamide
PubChem CID: 158715582
2D Structure
Properties
C22H24N6O3
Molecular Formula
426.50
Molecular Weight
g/mol
426.2286
Exact Mass
Da
2.8
XLogP
Drug-like (Lipinski: < 5)
111
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
7
H-Bond Acceptors
645
Complexity
SMILES
Canonical SMILES
SMILES: CCC(=O)C1=CN=C(C=C1NC2=CC=CC(=C2OC)C3=NN(C=N3)C)NC(=O)C4CC4Isomeric SMILES
SMILES: [2H]C([2H])([2H])CC(=O)C1=CN=C(C=C1NC2=CC=CC(=C2OC)C3=NN(C=N3)C([2H])([2H])[2H])NC(=O)C4CC4Synonyms(20)
envudeucitinibKD2MDJ4GAB2417135-66-9N-(4-(2-methoxy-3-(1-(trideuteriomethyl)-1,2,4-triazol-3-yl)anilino)-5-(3,3,3-trideuteriopropanoyl)pyridin-2-yl)cyclopropanecarboxamideN-[4-[2-methoxy-3-[1-(trideuteriomethyl)-1,2,4-triazol-3-yl]anilino]-5-(3,3,3-trideuteriopropanoyl)pyridin-2-yl]cyclopropanecarboxamideRefChem:1084119Envudeucitinibumenvudeucitinib [INN]Envudeucitinib (USAN/INN)ENVUDEUCITINIB [USAN]CHEMBL5415395ESK 001 [WHO-DD]SCHEMBL30697049GTPL13205ESK-001
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Envudeucitinib
Loading drug network...